TCR-T cell therapy for solid tumors: challenges and emerging solutions
With the use of T cell receptor T cells (TCR-T cells) and chimeric antigen receptor T cells (CAR-T cells), T-cell immunotherapy for cancer has advanced significantly in recent years. CAR-T cell therapy has demonstrated extraordinary success when used to treat hematologic malignancies. Nevertheless,...
Saved in:
| Main Authors: | Wanjun He, Kai Cui, Muhammad Asad Farooq, Na Huang, Songshan Zhu, Dan Jiang, Xiqian Zhang, Jian Chen, Yinxia Liu, Guangxian Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1493346/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clonal Analysis of Peripheral Blood T Cells in patients with Hashimoto's Thyroiditis at Different Stages using TCR Sequencing
by: Yufeng Liu, et al.
Published: (2025-05-01) -
Deciphering the deterministic role of TCR signaling in T cell fate determination
by: Zhen Qin, et al.
Published: (2025-05-01) -
A comprehensive evaluation of diversity measures for TCR repertoire profiling
by: Justyna Mika, et al.
Published: (2025-05-01) -
Exploiting TCR Repertoire Analysis to Select Therapeutic TCRs for Cancer Immunotherapy
by: Ursule M. Demaël, et al.
Published: (2025-08-01) -
Mutant p53-specific CD8TCR-therapy combined with a CD4TCR prevents relapse of cancer and outgrowth of micrometastases
by: Vasiliki Anastasopoulou, et al.
Published: (2025-12-01)